Sort   by:  
 Page size 
ProteomicsProteomic analysis of E. coli K-12 LE392, P. putida KT2440 under exposure of six non-antibiotic pharmaceuticals
The goals of this study are to use SWATH-MS to detect bacterial proteomic profiles of E. coli K-12 LE392 with conjugative RP4 plasmid, P. putida KT2440, and their protein response under the exposure of six kinds of non-antibiotic pharmaceuticals, i.e., ibuprofen (ibu), naproxen (nap), gemfibrozil (g...
ORGANISM(S): Escherichia coli Pseudomonas putida KT2440 
2022-02-15 | PXD012642 | Pride
Non-antibiotic pharmaceuticals Swath-ms P. putida E. coli 
ProteomicsProteomic analysis of Acinetobacter baylyi ADP1 under exposure of non-antibiotic pharmaceuticals
The goals of this study are to use SWATH-MS to detect bacterial proteomic profiles of wild-type Acinetobacter baylyi ADP1, and its protein response under the exposure of non-antibiotic pharmaceuticals, including ibuprofen, naproxen, gemfibrozil, diclofenac, propanolol, and iopromide. The concentrati...
ORGANISM(S): Acinetobacter sp. 
2020-05-22 | PXD016798 | Pride
Bacteria Non-antibiotic pharmaceuticals Swath-ms Acinetobacter baylyi adp1 
ProteomicsProteome of Pseudomonas aeruginosa treated by non-antibiotic pharmaceutical
Antimicrobial resistance (AMR) has been an increasingly serious threat to global public health. The contribution of non-antibiotic pharmaceuticals to the development of antibiotic resistance has been overlooked.Proteomic analysis was used to explore the underlying mechanism of AMR caused by non-ant...
ORGANISM(S): Pseudomonas Aeruginosa Pao1 
2024-01-26 | PXD048908 |
UnknownNon-antibiotic pharmaceuticals enhance the transmission of exogenous antibiotic resistance genes through bacterial transformation.
Not available
S-EPMC7367833 | biostudies-literature
UnknownNon-antibiotic pharmaceuticals promote conjugative plasmid transfer at a community-wide level.
Not available
S-EPMC9373378 | biostudies-literature
GenomicsNext Generation Sequencing Facilitates Quantitative Analysis of Wild Type and non-antibiotic pharmaceuticals stressed Acinetobacter baylyi ADP1 Transcriptomes
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and non-antibiotic pharmaceuticals stressed Acinetobacter baylyi ADP1 Transcriptomes
PRJNA595841 | ENA
TranscriptomicsNext Generation Sequencing Facilitates Quantitative Analysis of Wild Type and non-antibiotic pharmaceuticals stressed Acinetobacter baylyi ADP1 Transcriptomes
The goals of this study are to use Next-generation sequencing (NGS) to detect bacterial mRNA profiles of wild-type A.baylyi ADP1, and its mRNA response under the exposure of six non-antibiotic pharmaceuticals, including ibuprofen, naproxen, gemfibrozil, diclofenac, propanolol, and iopromide. The con...
ORGANISM(S): Acinetobacter baylyi 
2020-07-22 | GSE142061 | GEO
UnknownNon-antibiotic pharmaceuticals are toxic against Escherichia coli with no evolution of cross-resistance to antibiotics.
Not available
S-EPMC11721113 | biostudies-literature
TranscriptomicsNext Generation Sequencing Facilitates Quantitative Analysis of Wild Type and non-antibiotic pharmaceuticals stressed E. coli K-12 LE392, P. putida KT2440, and RP4 plasmid Transcriptomes [experiment 1]
The goals of this study are to use Next-generation sequencing (NGS) to detect bacterial mRNA profiles of wild-type E. coli K-12 LE392, P. putida KT2440 and IncPα RP4 plasmid, and their mRNA response under the exposure of six non-antibiotic pharmaceuticals, including ibuprofen, naproxen, gemfibrozil,...
ORGANISM(S): Pseudomonas putida KT2440 Plasmid RP4 Escherichia coli K-12 
2021-09-01 | GSE130562 | GEO
GenomicsCommon non-antibiotic drugs enhance selection for antimicrobial resistance in mixture with ciprofloxacin
Non-antibiotic drugs enhance AMR in mixture with ciprofloxacin
PRJEB88784 | ENA
Sort   by:  
 Page size